PBE Among Technology ETFs
End-of-day Nov 18, 2026 · 58 Technology ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.3% | −4.3% | −3.3% | −0.6% | +18.1% | +25.7% | +81.7% | +35.9% | +158.2% | +436.9% |
| Peer average | +0.3% | −6.2% | −9.7% | −12.1% | +2.0% | +5.0% | +65.2% | +23.5% | +365.5% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$59 of every $1,000 in PBE is Regeneron
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | REGNRegeneron Pharmaceuticals | Healthcare | 5.92% | $591.58 | 26K | $25.2M |
| 2 | GILDGilead Sciences | Healthcare | 5.89% | $589.30 | 147K | $25.1M |
| 3 | BIIBBiogen | Healthcare | 5.85% | $584.97 | 99K | $24.9M |
| 4 | RPRXRoyalty Pharma | Healthcare | 5.70% | $569.74 | 353K | $24.2M |
| 5 | AMGNAmgen | Healthcare | 5.33% | $533.22 | 50K | $22.7M |
| 6 | VRTXVertex Pharmaceuticals | Healthcare | 4.98% | $497.51 | 40K | $21.2M |
| 7 | ILMNIllumina | Healthcare | 4.64% | $463.68 | 97K | $19.7M |
| 8 | NTRANatera | Healthcare | 4.40% | $439.63 | 65K | $18.7M |
| 9 | VCELVericel | Healthcare | 3.76% | $376.13 | 276K | $16.0M |
| 10 | MRNAModerna | Healthcare | 3.66% | $365.68 | 75K | $15.6M |
| 11 | EXELExelixis | Healthcare | 3.39% | $339.20 | 211K | $14.4M |
| 12 | QGENQiagen | Healthcare | 3.20% | $320.11 | 274K | $13.6M |
| 13 | TGTXTG Therapeutics | Healthcare | 3.18% | $317.81 | 216K | $13.5M |
| 14 | UTHRUnited Therapeutics | Healthcare | 3.16% | $316.40 | 23K | $13.5M |
| 15 | NBIXNeurocrine Biosciences | Healthcare | 3.04% | $303.83 | 78K | $12.9M |
of the $345B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | REGN | Regeneron Pharmaceuticals | 5.92% |
| 2 | GILD | Gilead Sciences | 5.89% |
| 3 | BIIB | Biogen | 5.85% |
| 4 | RPRX | Royalty Pharma | 5.70% |
| 5 | AMGN | Amgen | 5.33% |
| 6 | VRTX | Vertex Pharmaceuticals | 4.98% |
| 7 | ILMN | Illumina | 4.64% |
| 8 | NTRA | Natera | 4.40% |
| 9 | VCEL | Vericel | 3.76% |
| 10 | MRNA | Moderna | 3.66% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.0187 |
| Jun 22, 2026 | Jun 26, 2026 | $0.81 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0824 |
| Dec 22, 2025 | Dec 26, 2025 | $0.42 |
| Sep 22, 2025 | Sep 26, 2025 | $0.23 |
| Jun 23, 2025 | Jun 27, 2025 | $0.13 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0341 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0082 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0242 |
| Jun 20, 2023 | Jun 23, 2023 | $0.0141 |
| Mar 23, 2020 | Mar 31, 2020 | $0.0290 |
| Sep 24, 2018 | Sep 28, 2018 | $0.0021 |